MiR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells

Medical Oncology

Volumn 31, Issue 4, 2014, Pages

  She, Xiaoling ^a,b,c   Yu, Zhibin ^a,b,d   Cui, Yulong ^c   Lei, Qianqian ^a,b,d   Wang, Zeyou ^a,b,d   Xu, Gang ^a,b,d   Luo, Zhaohui ^a   Li, Guiyuan ^a,b   Wu, Minghua ^a,b,d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d The Center for Skull Base Surgery and Neurooncology   (China)

Author keywords

Cytoskeleton; F actin; Glioblastoma; miR 181; Temozolomide

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MICRORNA; MICRORNA 181; MICRORNA 181A; MICRORNA 181B; MICRORNA 181C; MICRORNA 181D; NERVE CELL ADHESION MOLECULE; PROTEIN CDC42; RAP1B PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TEMOZOLOMIDE; UNCLASSIFIED DRUG; ACTIN; ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE; MIRN181 MICRORNA, HUMAN; RAP PROTEIN; RAP1B PROTEIN, HUMAN;

ACTIN FILAMENT; ARTICLE; BRAIN TISSUE; BRAIN TUMOR; CARCINOGENESIS; CELL KILLING; CHEMOSENSITIVITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY MECHANISM; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; CELL MOTION; CELL PROLIFERATION; CYTOSKELETON; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

ACTINS; ANTINEOPLASTIC AGENTS, ALKYLATING; BASE SEQUENCE; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETON; DACARBAZINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; RAP GTP-BINDING PROTEINS; UP-REGULATION;

EID: 84894286490     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0892-9     Document Type: Article

References (38)

1. Chen L, Zhang Y, Yang J, Hagan JP, Li M. Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies. Biochim Biophys Acta. 2013;1836:158-65. doi: 10.1016/j.bbcan.2013.04.003.
2. Lwin Z, Macfadden D, Al-Zahrani A, Atenafu E, Miller BA, Sahgal A, Menard C, Laperriere N, Mason WP. Glioblastoma management in the temozolomide era: have we improved outcome? J Neurooncol. 2013;115:303-10. doi: 10.1007/s11060-013-1230-3.
3. Menéndez P, Villarejo P, Padilla D, Menéndez JM, Rodríguez-Montes JA. Implications of the histological determination of microRNAs in the screening, diagnosis and prognosis of colorectal cancer. J Surg Oncol. 2013;108:70-3. doi: 10.1002/jso.23344.
4. Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol. 2013;15:546-54. doi: 10.1038/ncb2769.
5. Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 2010;1352:255-64. doi: 10.1016/j.brainres.2010.07.009.
6. Wong ST, Zhang XQ, Zhuang JT, Chan HL, Li CH, Leung GK. MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells. Anticancer Res. 2012;32:2835-41.
7. Qian X, Ren Y, Shi Z, Long L, Pu P, Sheng J, Yuan X, Kang C. Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy. Mol Pharm. 2012;9:2636-45. doi: 10.1021/mp3002039.
8. Ujifuku K, Mitsutake N, Takakura S, Matsuse M, Saenko V, Suzuki K, Hayashi K, Matsuo T, Kamada K, Nagata I, Yamashita S. miR-195, miR-455-3p and miR-10a(*) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett. 2010;296:241-8. doi: 10.1016/j.canlet.2010.04.013.
9. Zhang S, Wan Y, Pan T, Gu X, Qian C, Sun G, Sun L, Xiang Y, Wang Z, Shi L. MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide. J Mol Neurosci. 2012;47:346-56. doi: 10.1007/s12031-012-9759-8.
10. Liu G, Min H, Yue S, Chen CZ. Pre-miRNA loop nucleotides control the distinct activities of mir-181a-1 and mir-181c in early T cell development. PLoS ONE. 2008;3:e3592. doi: 10.1371/journal.pone.0003592.
11. Henao-Mejia J, Williams A, Goff LA, Staron M, Licona-Limón P, Kaech SM, Nakayama M, Rinn JL, Flavell RA. The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity. 2013;38:984-97. doi: 10.1016/j.immuni. 2013.02.021.
12. Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, McCarthy JB, She X, Zhang W, Ma J, Xiong W, Wu M, Lu J, Li X, Li X, Xiang J, Li G. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis. 2013;34:415-25. doi: 10.1093/carcin/bgs329.
13. Neel JC, Lebrun JJ. Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. Cell Signal. 2013;25:1556-66. doi: 10.1016/j.cellsig.2013.03.013.
14. Ji J, Yamashita T, Budhu A, Forgues M, Jia HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, Qin LX, Yang W, Wang HY, Tang ZY, Croce CM, Wang XW. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology. 2009;50:472-80. doi: 10.1002/hep.22989.
15. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, You Y. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008;1236:185-93. doi: 10.1016/j.brainres.2008.07.085.
16. Zhang W, Zhang J, Hoadley K, Kushwaha D, Ramakrishnan V, Li S, Kang C, You Y, Jiang C, Song SW, Jiang T, Chen CC. miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression. Neuro-Oncology. 2012;14:712-9. doi: 10.1093/neuonc/nos089.
17. Ilhan-Mutlu A, Wöhrer A, Berghoff AS, Widhalm G, Marosi C, Wagner L, Preusser M. Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens. J Neurooncol. 2013;112:347-54. doi: 10.1007/s11060-013-1078-6.
18. Li D, Chen P, Li XY, Zhang LY, Xiong W, Zhou M, Xiao L, Zeng F, Li XL, Wu MH, Li GY. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. OMICS. 2011;15:673-82. doi: 10.1089/omi 2011.0064.
19. Wittchen ES, Aghajanian A, Burridge K. Isoform-specific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions. Small GTPases. 2011;2:65-76.
20. Schwamborn JC, Müller M, Becker AHM, Puschel AW. Ubiquitination of the GTPase Rap1B by the ubiquitin ligase Smurf2 is required for the establishment of neuronal polarity. EMBO J. 2007;26:1410-22.
21. Carmona G, Göttig S, Orlandi A, Scheele J, Bäuerle T, Jugold M, Kiessling F, Henschler R, Zeiher AM, Dimmeler S, Chavakis E. Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis. Blood. 2009;113:488-97. doi: 10.1182/blood-2008-02-138438.
22. Fischer U, Keller A, Leidinger P, Deutscher S, Heisel S, Urbschat S, Lenhof HP, Meese E. A different view on DNA amplifications indicates frequent, highly complex, and stable amplicons on 12q13-21 in glioma. Mol Cancer Res. 2008;6:576-84. doi: 10.1158/1541-7786.
23. Malchinkhuu E, Sato K, Maehama T, Ishiuchi S, Yoshimoto Y, Mogi C, Kimura T, Kurose H, Tomura H, Okajima F. Role of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid-induced migration by isoproterenol in glioma cells. Mol Biol Cell. 2009;20:5156-65. doi: 10.1091/mbc.E09-08-0692.
24. Zhang M, Zhou S, Zhang L, Zhang J, Cai H, Zhu J, Huang C, Wang J. miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma. FEBS Lett. 2012;586:3508-21. doi: 10.1016/j.febslet.2012.08.007.
25. Guo H, Hu X, Ge S, Qian G, Zhang J. Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. Int J Biochem Cell Biol. 2012;44:1465-72. doi: 10.1016/j.biocel.2012.05.015.
26. Tang H, Wang Z, Liu X, Liu Q, Xu G, Li G, Wu M. LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway. Curr Cancer Drug Targets. 2012;12:1032-42.
27. Pletsas D, Garelnabi EA, Li L, Phillips RM, Wheelhouse RT. Synthesis and quantitative structure-activity relationship of imidazotetrazine prodrugs with activity independent of O6-methylguanine-DNA-methyltransferase, DNA mismatch repair and p53. Med Chem. 2013;56:7120-32. doi: 10.1021/jm401121k.
28. Yin J, Wang C, Mody A, Bao L, Hung SH, Svoronos SA, Tseng Y. The effect of Z-ligustilide on the mobility of human glioblastoma T98G cells. PLoS ONE. 2013;8:e66598.
29. White GC II, Crawford N, Fischer TH. Cytoskeletal interactions of Rap1b in platelets. Adv Exp Med Biol. 1993;344:187-94.
30. Mizoguchi M, Guan Y, Yoshimoto K, Hata N, Amano T, Nakamizo A, Sasaki T. Clinical implications of microRNAs in human glioblastoma. Front Oncol. 2013;3:19. doi: 10.3389/fonc.2013.00019.
31. Huh JH, Kim TH, Kim K, Song JA, Jung YJ, Jeong JY, Lee MJ, Kim YK, Lee DH, An HJ. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. Br J Cancer. 2013;109:452-61. doi: 10.1038/bjc.2013.305.
32. Cai B, An Y, Lv N, Chen J, Tu M, Sun J, Wu P, Wei J, Jiang K, Miao Y. miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2. Oncol Rep. 2013;29:1769-76. doi: 10.3892/or 2013.2297.
33. Costa PM, Cardoso AL, Nóbrega C, Pereira de Almeida LF, Bruce JN, Canoll P, Pedroso de Lima MC. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma. Hum Mol Genet. 2013;22:904-18. doi: 10.1093/hmg/dds496.
34. Guo Y, Yan K, Fang J, Qu Q, Zhou M, Chen F. Let-7b expression determines response to chemotherapy through the regulation of cyclin D1 in glioblastoma. J Exp Clin Cancer Res. 2013;32:41. doi: 10.1186/1756-9966-32-41.
35. Wang J, Sai K, Chen FR, Chen ZP. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. Cancer Chemother Pharmacol. 2013;72:147-58. doi: 10.1007/s00280-013-2180-3.
36. Frische EW, Zwartkruis FJ. Rap1, a mercenary among the Ras-like GTPases. Dev Biol. 2010;340:1-9. doi: 10.1016/j.ydbio.2009.12.043.
37. Bos JL. Linking RAP to cell adhesion. Curr Opin Cell Biol. 2005;17:123-8.
38. Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett. 2008;582:2093-101. doi: 10.1016/j.febslet.2008.04.039.